Market Tracker

05/18 5:15pm ET

Endo International PLC (NASDAQ:ENDP)

6.10
Delayed Data
As of May 18
 -0.10 / -1.61%
Today’s Change
5.27
Today|||52-Week Range
14.15
-21.29%
Year-to-Date
What Does Francis Chou See in Valeant?
May 15 / GuruFocus News - Paid Partner Content
Is the Options Market Predicting a Spike in Endo International (ENDP) Stock?
May 08 / Zacks.com - Paid Partner Content
BioDelivery (BDSI) Q1 Earnings and Sales Beat Estimates
May 11 / Zacks.com - Paid Partner Content
Factors Likely to Impact Zillow (ZG) This Earnings Season
May 07 / Zacks.com - Paid Partner Content
Xiaflex & Sterile Injectables Drive Endo's (ENDP) Q1 Earnings
May 10 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close6.20
Today’s open6.21
Day’s range6.01 - 6.21
Volume4,005,213
Average volume (3 months)5,355,207
Market cap$1.4B
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)+39.32%
Earnings growth (this year)-38.10%
Earnings growth (next 5 years)-11.80%
Revenue growth (last year)-13.50%
P/E ratioNM
Price/Sales0.50
Price/Book2.86

Competitors

 Today’s
change
Today’s
% change
AERIAerie Pharmaceutical...0.000.00%
AXONAxovant Sciences Ltd+0.07+5.69%
HZNPHorizon Pharma PLC+0.04+0.27%
CORTCorcept Therapeutics...+0.58+3.23%
Data as of 4:00pm ET, 05/18/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)$0.58
Annual revenue (last year)$3.5B
Annual profit (last year)-$2.0B
Net profit margin-35.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul V. Campanelli
Chief Operating Officer &
Executive Vice President
Terrance J. Coughlin
Corporate headquarters
Dublin, Dublin

Forecasts